🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to find out whether the combination of botensi...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-02-20
Trial ID
NCT06843434
Treatments Being Tested
This is a phase I, open label, plus expansion clinical trial evaluating the...
Status
Recruiting
Location
Children's Health Orange County (CHOC)
Start Date
2022-01-10
Trial ID
NCT04943848
Treatments Being Tested
This phase II trial studies how well the combination of botensilimab, balst...
Status
Withdrawn
Location
Multiple Locations
Start Date
2024-11-01
Trial ID
NCT06575725
The goal of this study is to see if the drug balstilimab is safe and effect...
Status
Recruiting
Location
Hematology Center named after prof. R. Yeolyan
Start Date
2023-09-01
Trial ID
NCT05891821
Treatments Being Tested
The researchers are doing this study to find out whether the combination of...
Status
Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Start Date
2025-11-07
Trial ID
NCT07227636
Treatments Being Tested
This study is being done to answer the main question of: Do patients with c...
Status
Terminated
Location
Kingston Health Science Centre
Start Date
2026-03-31
Trial ID
NCT07152821
Treatments Being Tested
This study is an open-label, Phase 1 study to evaluate the safety, tolerabi...
Status
Terminated
Location
HonorHealth Research Institute
Start Date
2019-12-10
Trial ID
NCT04156100
Treatments Being Tested
This is an open-label, non-randomized, single-institution, single arm Phase...
Status
Active Not Recruiting
Location
University of Colorado Hospital
Start Date
2020-01-28
Trial ID
NCT04028063
Treatments Being Tested
This study aims to leverage this unique property of HPV+ OPC to detect poss...
Status
Withdrawn
Location
Multiple Locations
Start Date
2023-10-18
Trial ID
NCT05363709
Treatments Being Tested
CIME is a multicenter, randomised, comparative, open-label phase III study ...
Status
Recruiting
Location
CHU de Brest
Start Date
2025-12-08
Trial ID
NCT06346197
Treatments Being Tested